The role of signaling pathways in the development and treatment of hepatocellular carcinoma.
about
Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesisAnalysis of protein-protein interactions in cross-talk pathways reveals CRKL protein as a novel prognostic marker in hepatocellular carcinomaAntiproliferative small-molecule inhibitors of transcription factor LSF reveal oncogene addiction to LSF in hepatocellular carcinomaLinks between Human LINE-1 Retrotransposons and Hepatitis Virus-Related Hepatocellular CarcinomaMolecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advancesEpigenetic regulation of insulin-like growth factor axis in hepatocellular carcinomaMetabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genesGroup II p21-activated kinases as therapeutic targets in gastrointestinal cancerHistone Deacetylases and Their Regulatory MicroRNAs in HepatocarcinogenesisFrizzled7 as an emerging target for cancer therapyTargeting the insulin-like growth factor pathway in hepatocellular carcinomaChemotherapeutic agents for the treatment of hepatocellular carcinoma: efficacy and mode of actionActivation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinomaCombination treatment including targeted therapy for advanced hepatocellular carcinomaStem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancerAberrant regulation of Wnt signaling in hepatocellular carcinomaPrevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challengesDysregulated serum response factor triggers formation of hepatocellular carcinomaDickkopfs and Wnt/β-catenin signalling in liver cancerCapture of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signalingRegulation of amphiregulin gene expression by β-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR systemRecombinant human acid sphingomyelinase as an adjuvant to sorafenib treatment of experimental liver cancerTherapeutic potential of the translation inhibitor silvestrol in hepatocellular cancerProdrug AST-003 Improves the Therapeutic Index of the Multi-Targeted Tyrosine Kinase Inhibitor SunitinibTrisubstituted-Imidazoles Induce Apoptosis in Human Breast Cancer Cells by Targeting the Oncogenic PI3K/Akt/mTOR Signaling PathwayEffect of liver regeneration on malignant hepatic tumorsImpact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinomaSorafenib-resistant hepatocellular carcinoma stratified by phosphorylated ERK activates PD-1 immune checkpointIntegrative quantitative proteomics unveils proteostasis imbalance in human hepatocellular carcinoma developed on nonfibrotic livers.Therapeutic utilities of fibroblast growth factor 19.An oncogenic role of Agrin in regulating focal adhesion integrity in hepatocellular carcinomaIdentification of functional modules by integration of multiple data sources using a Bayesian network classifierIntegrated analysis of mutation data from various sources identifies key genes and signaling pathways in hepatocellular carcinoma.Hedgehog signaling pathway mediates invasion and metastasis of hepatocellular carcinoma via ERK pathway.WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancer.Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway.GGPPS1 predicts the biological character of hepatocellular carcinoma in patients with cirrhosisβ-Catenin transcriptional activity is minimal in canine osteosarcoma and its targeted inhibition results in minimal changes to cell line behaviour.The cell polarity protein Scrib functions as a tumor suppressor in liver cancer.
P2860
Q24298462-7EF7F4D1-D190-49F4-82A9-7E9F1ACF1710Q24316017-EF64CA88-C514-4790-A0BF-8EAB83AAE8C7Q24610751-3CA3BD91-6EF4-4C2C-8B71-3356EADB80AFQ26744497-47BBA179-5EAD-4AB5-88C8-D9D5071A3521Q26745338-E1394F56-3B8D-4C95-B34B-67E876C2815FQ26766068-A7C39C1F-8CC1-472F-8E68-8CABD01C68B8Q26769611-01CFF65D-478F-46C6-BAF9-EDF6D125EF59Q26772317-C9E1AA89-973D-4EC8-8993-3F4D55ED07A9Q26774494-8E3A8E1E-E4E8-491C-BB78-38588D82C6D4Q26783620-2E151E6D-CC61-4E1A-B7B0-080E1FD7279DQ26849278-98850640-EE69-44BE-AF0B-28C719CC331DQ27006846-86DD756A-B6C3-4965-8AE0-23B2B44366E5Q27693179-FEDF4128-7027-49E0-A0E3-3F539599A4B4Q27851797-AB17521B-F0FB-4D50-AC8D-750A2FD5DD70Q28077738-F9BD38D5-873E-499C-9F42-DC086568DA79Q28079205-328E8863-B6B9-4166-9F63-0A04558BF04AQ28079789-498DD53D-C293-4FFC-88C1-893AC944220EQ28272678-B2852570-9DC7-4F4C-8985-6016C2058131Q28390147-A817568D-7FBF-4A00-91B2-07E430389673Q28391394-A5851D8A-398E-42AC-BA82-419DE8AE950FQ28477912-CCA07F75-75CA-4FA4-A8B6-43B5F41313F2Q28484499-BFF699D1-BE98-47F0-966E-8E593B6F2DBCQ28533335-89F7A6F7-898D-4892-A0A4-A299BF46016CQ28533823-83E8F8BA-3C76-49A2-8C20-DE7C57B10ABCQ28550556-51AB4824-684A-49B2-9E49-FB72F7D6EBBFQ28551465-4D37497B-BEFA-4F58-876B-D563A52BA3D1Q28651675-DF4A2828-6726-42BD-AF27-4904414E154FQ28730441-DBAA38AB-6F58-4F38-8917-26450C290097Q28816970-8AB1C30D-BD64-492E-9E32-3D25AAA6C1C2Q30397531-D1545CEF-26C5-40A0-8BE5-339AAC5FE1B6Q30407643-2A8A4DCE-3E51-4245-87EE-61C891E778C7Q30619662-49306B98-5C2B-4608-9A7C-95A3B430A1CCQ30801881-9A61C16B-161D-44E8-8BDA-275BF7469254Q30834745-D61B165C-E048-4289-8A7D-098A0BFCF6D5Q33567426-B22BBC25-11BD-464B-A5BE-760CFF1D0AA8Q33572324-A0B05178-65AF-4847-BABF-43D9ACB4C5ECQ33631453-511749C7-84BC-4B3E-916B-E77816E16102Q33638516-98EBEE8F-B960-4D7F-87E6-72CADF81E382Q33645914-777AE365-516C-4962-B744-2A192DA054E6Q33688728-95B253A9-CED0-434E-8702-9B9DCF011F01
P2860
The role of signaling pathways in the development and treatment of hepatocellular carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of signaling pathways ...... t of hepatocellular carcinoma.
@en
The role of signaling pathways ...... t of hepatocellular carcinoma.
@nl
type
label
The role of signaling pathways ...... t of hepatocellular carcinoma.
@en
The role of signaling pathways ...... t of hepatocellular carcinoma.
@nl
prefLabel
The role of signaling pathways ...... t of hepatocellular carcinoma.
@en
The role of signaling pathways ...... t of hepatocellular carcinoma.
@nl
P356
P1433
P1476
The role of signaling pathways ...... t of hepatocellular carcinoma.
@en
P2093
P2888
P304
P356
10.1038/ONC.2010.236
P407
P577
2010-07-19T00:00:00Z